Sign in
ARDX Stock Price, Chart, Stats & News
Ardelyx, Inc.
Save
1.55B
Market cap
–
Current P/E
40.65x
Forward P/E
ARDX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 90.29% |
Operating margin | -10.06% |
Pretax margin | -14.89% |
Net margin | -15.12% |
Effective tax rate | -1.60% |
ROA | -12.25% |
ROE | -40.63% |
D/E | 1.27x |
Interest coverage ratio | -1.44x |
ARDX valuation
P/E | – |
P/S | 3.30x |
P/B | 8.00x |
P/CF | -31.42x |
P/FCF | -30.56x |
P/OCF | -31.42x |
PEG | 1.66x |
EV multiple | -41.15x |
About
Ardelyx, Inc. is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of innovative medicines. The company primarily focuses on addressing gastrointestinal (GI) and cardiorenal conditions, serving patients both domestically in the United States and across international markets. Its flagship product candidate is tenapanor.
Similar securities
Based on sector and market capitalization
Report issue